Consequently, there is a need for efficient and sensitive reporter assays to elucidate LDLR regulation and function under various conditions, screen for compounds that affect its activity, and model related diseases, all of which are essential for developing treatments for hyperlipidemia and cardiovascular diseases (Roger et al., 2012). The gene discussed is LDLR; the disease is hyperlipidemia.